COVID-19 pneumonia in kidney transplant recipients-Where we are?
David José de Barros MachadoLuiz Estevam IanhezPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
In late December 2019, China reported cases of respiratory illness in humans that involved a novel coronavirus SARS-CoV-2. On March 20, 2020, the first coronavirus disease 2019 (COVID-19) in Brazil was diagnosed, and by now, we present the report on the first case of COVID among transplant recipients in our country. A liver and kidney transplant patient with SARS-CoV-2 pneumonia without respiratory failure was treated in a clinical multimodal strategy consisting of symptomatic support therapy, immunosuppression reduction, use of anti-coronavirus drugs and heparin leading to a progressive improvement of patient symptoms till discharge. The authors also present a comprehensive review of published cases.
Keyphrases
- sars cov
- coronavirus disease
- respiratory failure
- respiratory syndrome coronavirus
- case report
- extracorporeal membrane oxygenation
- mechanical ventilation
- multiple sclerosis
- venous thromboembolism
- intensive care unit
- randomized controlled trial
- mesenchymal stem cells
- physical activity
- systematic review
- cell therapy
- sleep quality
- drug induced
- meta analyses